ARTICLE SUMMARY:
Three-year-old Bioventus aims to bring innovation backed by high-level clinical evidence to the murky field of orthobiologics, including new approaches to the controversial area of BMP growth factors.
The field of orthobiologics has an important but unclear role to play in the success of orthopedic surgeries, particularly in spine fusion, patients at risk of non-unions or impaired bone regeneration, and orthopedic procedures with high non-union rates, such as tibia diaphysis.
